4 completed, 2 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 4, Terminated 2 |
Follow Ferrer Internacional S.A.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting Staccato® Delivery System Loxapine (ADASUVE®) - Agitation | Phase 4 | Completed | Ferrer Internacional S.A. | 323 | 2016-09-08 | 2020-11-04 |
| Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms Omega-3, Soy Isoflavones - Menopause, Hot Flashes | Phase 4 | Completed | Instituto Palacios | 75 | 2014-03-01 | 2016-09-16 |
| Single Dose Study to Compare the Pharmacodynamics of Torasemide-PR 10 mg,Torasemide-IR 10 mg and Furosemide-IR 40 mg in Patients With Compensated Heart Failure torasemide-PR, Furosemide-IR, torasemide-IR - Compensated Heart Failure | Phase 4 | Terminated | Ferrer Internacional S.A. | 8 | 2012-02-01 | 2013-04-25 |
| Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children ciclopirox - Dermatomycoses | Phase 4 | Terminated | Ferrer Internacional S.A. | 21 | 2008-10-01 | 2012-07-20 |
| Effect of a New Formulation of Torasemide (Prolonged Release)on Myocardial Fibrosis in Patients With Heart Failure. Torasemide Prolonged Release, Furosemide - Congestive Heart Failure | Phase 4 | Completed | Ferrer Internacional S.A. | 142 | 2007-03-01 | 2009-07-15 |
| Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension. Torasemide Prolonged Release (loop diuretic), Torasemide Immediate Release (loop diuretic) - Hypertension | Phase 4 | Completed | Ferrer Internacional S.A. | 388 | 2005-04-01 | 2015-03-06 |
Bipolar Disorder (1) · Candidiasis (1) · Dermatomycoses (1) · Heart Failure (1) · Hot Flashes (1) · Hypertension (1) · Psychomotor Agitation (1) · Schizophrenia (1) · Tinea (1)
Ciclopirox (1) · Docosahexaenoic Acids (1) · Furosemide (1) · Sodium Potassium Chloride Symporter Inhibitors (1) · Soybean Proteins (1) · Torsemide (1)
Spain (4)
Antonio Coca, MD, PhD (2) · Alex Roca, MD, PhD (1) · Alexander O Sherenkov, MD, PhD (1) · Alexander V Orlov-Morozov, MD, PhD (1) · Alfonso Castro Beiras, MD, PhD (1) · Andrei Y Baranovsky, MD, PhD (1) · Angel Cano, MD (1) · Angela Felip, MD, PhD (1) · Blas Gil, MD (1) · Boris M Goloschekin, MD, PhD (1) · Carles Brotons, MD, PhD (1) · Carlos Calvo, MD, PhD (1) · Eduardo De Teresa, MD, PhD (1) · Elena F Pavlysh, MD, PhD (1) · Emili Marco, MD (1)
PMID 19673667, PMID 21906812, PMID 26273191, PMID 30282677
2008 (1)